Patents by Inventor Feng Sui

Feng Sui has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • New use of neferine
    Publication number: 20130116276
    Abstract: The present invention reveals a new use of neferine. Neferine regulates M8 and V1 subtype of transient receptor potential ion channel (TRPM8 and TRPV1), respectively, in mammalians, including humans, and can be used for preparing medicaments for treating disease related to said ion channel (such as hyperalgesia, Parkinson's disease, painful bladder syndrome, chronic obstructive pulmonary disease, and tumor of skin, prostate, mammary gland, lung, colon, etc). The potency of neferine in the present invention is higher than that of hexahydrothymol.
    Type: Application
    Filed: April 13, 2010
    Publication date: May 9, 2013
    Applicant: Institute of Chinese Materia Medica, Chinese Academy of Medical Sciences
    Inventors: Tingliang Jiang, Feng Sui, Hairu Huo, Lanfang Li, Shuying Guo
  • New use of neferine
    Publication number: 20120108629
    Abstract: The present invention reveals a new use of neferine. Neferine regulates M8 and V1 subtype of transient receptor potential ion channel (TRPM8 and TRPV1), respectively, in mammalians, including humans, and can be used for preparing medicaments for treating disease related to said ion channel (such as hyperalgesia, Parkinson's disease, painful bladder syndrome, chronic obstructive pulmonary disease, and tumor of skin, prostate, mammary gland, lung, colon, etc). The potency of neferine in the present invention is higher than that of hexahydrothymol.
    Type: Application
    Filed: April 13, 2010
    Publication date: May 3, 2012
    Applicant: Institute of Chinese Materia Medica, China Academy
    Inventors: Tingliang Jiang, Feng Sui, Hairu Huo, Lanfang Li, Shuying Guo